⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7532721 | 0.84 | AOC3 (0.32) | — | |
| SCHEMBL7572011 | 0.77 | AOC3 (0.43) | — | |
| SCHEMBL12094877 | 0.66 | AOC3 (0.42) | — | |
| Trifluoroacetic Acid SCHEMBL7530146 | 0.65 | AOC3 (0.45) | — | |
| Trifluoroacetic Acid SCHEMBL7526771 | 0.62 | AOC3 (0.41) | — | |
| SCHEMBL7527633 | 0.62 | AOC3 (0.48) | — | |
| SCHEMBL7570588 | 0.60 | AOC3 (0.46) | — | |
| SCHEMBL7534337 | 0.58 | AOC3 (0.56) | — | |
| Hydrochloric Acid SCHEMBL11514974 | 0.58 | AOC3 (0.39) | — | |
| SCHEMBL7534329 | 0.57 | AOC3 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020198189-A1 | Treatment or prophylaxis of Semicarbazide-sensitive amine oxidase (SSAO) mediated complications in mammals including humans | BIOVITRUM AB (SE) | 2002-12-26 | — | — | US | claimed |
| WO-2002038153-A1 | NEW USE OF 4, 5, 6, 7-TETRAHYDROIMIDAZO-[4,5-C]PYRIDINE DERIVATIVES | BIOVITRUM AB (SE) | 2002-05-16 | — | — | WO | claimed |
| US-20020198189-A1 | Treatment or prophylaxis of Semicarbazide-sensitive amine oxidase (SSAO) mediated complications in mammals including humans | BIOVITRUM AB (SE) | 2002-12-26 | — | — | US | disclosed |
| WO-2002038153-A1 | NEW USE OF 4, 5, 6, 7-TETRAHYDROIMIDAZO-[4,5-C]PYRIDINE DERIVATIVES | BIOVITRUM AB (SE) | 2002-05-16 | — | — | WO | disclosed |